Structure-function analysis of RAMP1 - RAMP3 chimeras

Biochemistry

Volumn 49, Issue 3, 2010, Pages 522-531

  Qi, Tao ^c   Simms, John ^a,b   Bailey, Richard J ^c   Wheatley, Mark ^d   Rathbone, Dan L ^a   Hay, Debbie L ^c   Poyner, David R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR-LIKE RECEPTORS; CALCITONIN RECEPTORS; CONNECTING LOOPS; DUAL ROLE; EXTRACELLULAR; PEPTIDE BINDING; RECEPTOR ACTIVITY-MODIFYING PROTEINS; RECOGNITION SITE; STRUCTURE-FUNCTION ANALYSIS;

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CHIMERIC PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; GENE EXPRESSION; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ADRENOMEDULLIN; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; CERCOPITHECUS AETHIOPS; CONSERVED SEQUENCE; COS CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, CALCITONIN; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 74949097404     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9019093     Document Type: Article

References (24)

1. Hay, D. L., Poyner, D. R., and Sexton, P. M. (2006) GPCR modulation by RAMPs. Pharmacol. Ther. 109, 173-197.
2. McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., and Foord, S. M. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339.
3. Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., and Foord, S. M. (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54, 233-246.
4. Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., and Sexton, P. M. (2003) Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278, 3293-3297.
5. Muff, R., Buhlmann, N., Fischer, J. A., and Born, W. (1999) An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 140, 2924-2927.
6. Christopoulos, G., Perry,K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., and Sexton, P. M. (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56, 235-242.
7. Hay, D. L., Christopoulos, G., Christopoulos, A., Poyner, D. R., and Sexton, P. M. (2005) Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol. Pharmacol. 67, 1655-1665.
8. Kuwasako, K., Kitamura, K., Ito, K., Uemura, T., Yanagita, Y., Kato, J., Sakata, T., and Eto, T. (2001) The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors. J. Biol. Chem. 276, 49459-49465.
9. Kuwasako, K., Kitamura, K., Nagoshi, Y., Cao, Y. N., and Eto, T. (2003) Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J. Biol. Chem. 278, 22623-22630.
10. Kusano, S., Kukimoto-Niino, M., Akasaka, R., Toyama, M., Terada, T., Shirouzu, M., Shindo, T., and Yokoyama, S. (2008) Crystal structure of the human receptor activity-modifying protein 1 extracellular domain. Protein Sci. 17, 1907-1914.
11. Simms, J., Hay, D. L., Bailey, R. J., Konycheva, G., Bailey, G., Wheatley, M., and Poyner, D. R. (2009) Structure-function analysis of RAMP1 by alanine mutagenesis. Biochemistry 48, 198-205.
12. Mallee, J. J., Salvatore, C.A., LeBourdelles, B., Oliver, K.R., Longmore, J., Koblan, K. S., and Kane, S. A. (2002) Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J. Biol. Chem. 277, 14294-14298.
13. Hay, D. L., Christopoulos, G., Christopoulos, A., and Sexton, P. M. (2006) Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4- pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl) methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors - the role of receptor activity modifying protein 1. Mol. Pharmacol. 70, 1984-1991.
14. Qi, T., Christopoulos, G., Bailey, R. J., Christopoulos, A., Sexton, P. M., and Hay, D. L. (2008) Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol. Pharmacol. 74, 1059-1071.
15. Kuwasako, K., Kitamura, K., Onitsuka, H., Uemura, T., Nagoshi, Y., Kato, J., and Eto, T. (2002) Rat RAMP domains involved in adrenomedullin binding specificity. FEBS Lett. 519, 113-116.
16. Kuwasako, K., Kitamura, K., Nagata, S., and Kato, J. (2008) Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors. Biochem. Biophys. Res. Commun. 377, 109-113.
17. Pham, V., Wade, J. D., Purdue, B. W., and Sexton, P. M. (2004) Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor. J. Biol. Chem. 279, 6720-6729.
18. Bailey, R. J., and Hay, D. L. (2006) Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27, 1367-1375.
19. Bailey, R. J., and Hay, D. L. (2007) Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br. J. Pharmacol. 151, 678-687.
20. Wang, J. C. P., and Kollman, P. A. (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 21, 1049-1074.
21. Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005) The Amber biomolecular simulation programs. J. Comput. Chem. 26, 1668-1688.
22. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., and Klein, M. L. (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935.
23. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD - Visual Molecular Dynamics. J. Mol. Graphics 14, 33-38.
24. Bailey, R. J., Bradley, J. W., Poyner, D. R., Rathbone, D. L., and Hay, D. L. (2009) Functional characterization of two human receptor activity-modifying protein 3 variants. Peptides (in press).